February 28th 2021, 10:26pm
American Academy of Allergy, Asthma & Immunology
From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.
February 28th 2021, 9:52pm
American Academy of Allergy, Asthma & Immunology
How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.
February 28th 2021, 7:57pm
American Academy of Allergy, Asthma & Immunology
An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.
February 28th 2021, 6:44pm
American Academy of Allergy, Asthma & Immunology
In data presented during AAAAI 21, researchers compared the 2006 and 2016 versions of the diagnostic criteria proposed by the NIAD/FAAN.
February 28th 2021, 6:08pm
American Academy of Allergy, Asthma & Immunology
Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.
February 28th 2021, 5:16pm
American Academy of Allergy, Asthma & Immunology
Oxygen saturation levels similar for both asthma patients and non-asthma patients following mask use.
February 28th 2021, 12:45am
American Academy of Allergy, Asthma & Immunology
Late-breaking data show allegic children as young as 1-4 years old may have sustained benefit from daily peanut protein exposure.
February 28th 2021, 12:45am
American Academy of Allergy, Asthma & Immunology
An interview with a Children's Hospital Colorado investigator on new remote-monitoring research into children's adherence trends.
February 28th 2021, 12:30am
American Academy of Allergy, Asthma & Immunology
Trials testing hydroxychloroquine against COVID-19 have produced mixed results.
February 28th 2021, 12:30am
American Academy of Allergy, Asthma & Immunology
The adjusted allergy prevalence in recent years was 2.6% in infants who have been introduced to peanuts at 12 months.